is tirzepatide back on shortage list FDA reconsidering its decision to take off its drug Tirzepatide has been officially removed

This treatment is often recommended when lifestyle changes and other conservative treatments havent brought adequate relief

Injectable tirzepatide requires only one subcutaneous injection per week, eliminating daily medication management but requiring injection technique familiarity and comfort with needles

Freedom to titrate weekly doses as needed based on cravings

Underlying health conditions and medications Certain underlying health conditions such as diabetes, high blood pressure or kidney issues can affect how well tirzepatide works and how your body responds to the medication

Patients taking CagriSema lost 23% of their body weight under the efficacy analysis, compared with 25.5% for tirzepatide To view or add a comment, sign in New digital shield against metabolic disease in youth psychosis A new clinic-ready web-based risk prediction tool called PsyMetRiC is now available to forecast the risk of young people with psychosis developing cardiometabolic disorders such as obesity, metabolic syndrome and diabetes

PlexusDx offers tirzepatide through its Weight Management Protocols this article covers the mechanism, evidence, and genetic context that informs any decision to use it